High Court Won't Hear Sham Litigation Exception Case
The U.S. Supreme Court won't review a Third Circuit ruling that AbbVie delayed generic versions of its testosterone treatment AndroGel through sham litigation....To view the full article, register now.
Already a subscriber? Click here to view full article